IBERPAPEL GESTION, S.A. financials
IBERPAPEL GESTION, S.A.
959800RG37G8456RGX60 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €238.2M | €250.8M |
| Other income | €8.5M | €11.5M |
| Employee benefits expense | €24.4M | €22.9M |
| Raw materials & consumables used | €94.8M | €95.0M |
| Depreciation & amortisation | €13.2M | €12.8M |
| Operating profit (EBIT) | €25.1M | €52.8M |
| Net finance income / (cost) | €3.5M | €683.0K |
| Profit before tax | €28.6M | €53.4M |
| Income tax expense | €5.4M | €6.3M |
| Profit for the year | €23.2M | €47.1M |
| — attributable to owners | €23.2M | €47.1M |
| Total comprehensive income | €30.5M | €41.8M |
| Cash flow statement | ||
| Cash generated from operations | €42.8M | €33.0M |
| Net cash from operating activities | €41.4M | €33.0M |
| Net cash from investing activities | -€14.8M | €32.8M |
| Purchase of intangibles | €318.0K | €5.4M |
| Net cash from financing activities | -€18.4M | -€23.7M |
| Dividends paid | €10.8M | €9.6M |
| Repayments of borrowings | €7.6M | €13.5M |
| Balance sheet | ||
| Total assets | €407.7M | €389.0M |
| Non-current assets | €195.0M | €197.0M |
| Property, plant & equipment | €160.5M | €165.3M |
| Current assets | €212.6M | €192.1M |
| Inventories | €35.8M | €31.5M |
| Trade & other receivables | €37.3M | €37.1M |
| Cash & equivalents | €122.1M | €113.7M |
| Total equity | €339.6M | €318.4M |
| Non-current liabilities | €15.2M | €20.4M |
| Current liabilities | €52.9M | €50.2M |
| Trade & other payables | €37.0M | €33.2M |
| Deferred tax liabilities | €484.0K | €256.0K |
| Derived metrics | ||
| Operating margin | 10.5% | 21.0% |
| Net margin | 9.7% | 18.8% |
| Return on equity | 6.8% | 14.8% |
| Cash conversion ratio | 1.79× | 0.70× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €4.3M | -€5.2M |
| Adjustments For Decrease Increase In Trade and Other Receivables | €120.0K | -€8.7M |
| Adjustments For Depreciation and Amortisation Expense | €13.2M | €12.8M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | €1.3M | €1.9M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | -€176.0K | €93.0K |
| Adjustments For Income Tax Expense | €5.4M | €6.3M |
| Adjustments For Increase Decrease In Trade and Other Payables | -€3.8M | €23.5M |
| Adjustments For Interest Expense | €389.0K | €390.0K |
| Adjustments For Interest Income | €4.6M | €1.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €0 | -€22.5M |
| Adjustments For Provisions | €11.4M | €5.4M |
| Adjustments For Reconcile Profit Loss | €20.8M | -€4.4M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -€180.0K | €6.3M |
| Basic Earnings Loss Per Share From Continuing Operations | €2.12 | €4.42 |
| Changes In Inventories of Finished Goods and Work In Progress | -€3.7M | €9.8M |
| Comprehensive Income Attributable To Noncontrolling Interests | €0 | €0 |
| Comprehensive Income Attributable To Owners of Parent | €30.5M | €41.8M |
| Comprehensive Income From Continuing Operations | €30.5M | €41.8M |
| Current Provisions | €7.5M | €6.5M |
| Current Tax Liabilities Current | €2.5M | €4.2M |
| Deferred Tax Assets | €4.2M | €4.3M |
| Diluted Earnings Loss Per Share From Continuing Operations | €2.12 | €4.42 |
| Dividends Recognised As Distributions To Owners of Parent | €10.8M | — |
| Dividends Recognised As Distributions To Owners Per Share | €0.50 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €179.0K | -€338.0K |
| Equity and Liabilities | €407.7M | €389.0M |
| Gains Losses On Heldtomaturity Investments | €7.6M | €1.8M |
| Income Taxes Paid Refund Classified As Operating Activities | €5.7M | €854.0K |
| Increase Decrease In Cash and Cash Equivalents | €8.4M | €41.7M |
| Increase Decrease In Working Capital | -€1.2M | -€9.7M |
| Increase Decrease Through Transfers and Other Changes Equity | €1.4M | -€504.0K |
| Increase Decrease Through Treasury Share Transactions | €36.0K | -€574.0K |
| Intangible Assets Other Than Goodwill | €8.0M | €11.0M |
| Issue of Equity | €129.0K | €0 |
| Issued Capital | €6.6M | €6.5M |
| Liabilities | €68.1M | €70.6M |
| Noncurrent Biological Assets | €16.2M | €9.4M |
| Noncurrent Financial Assets | €6.1M | €7.0M |
| Noncurrent Provisions | €130.0K | €10.0K |
| Other Comprehensive Income | €7.3M | -€5.4M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €7.3M | -€5.4M |
| Other Current Assets | €17.4M | €9.8M |
| Other Inflows Outflows of Cash Classified As Operating Activities | €0 | €0 |
| Other Noncurrent Financial Liabilities | €2.1M | €2.2M |
| Other Operating Income Expense | -€92.9M | -€69.0M |
| Profit Loss From Continuing Operations | €23.2M | €47.1M |
| Profit Loss From Continuing Operations Attributable To Ordinary Equity Holders of Parent Entity | €0 | €0 |
| Reduction of Issued Capital | €0 | €0 |
| Reserve of Exchange Differences On Translation | -€10.0M | -€17.3M |
| Retained Earnings | €341.3M | €322.1M |
| Share Premium | €8.3M | €13.6M |
| Treasury Shares | €1.1M | €1.1M |
Every line item above is a fact tagged in IBERPAPEL GESTION, S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.